Advertisement
UK markets closed
  • FTSE 100

    7,895.85
    +18.80 (+0.24%)
     
  • FTSE 250

    19,391.30
    -59.37 (-0.31%)
     
  • AIM

    745.67
    +0.38 (+0.05%)
     
  • GBP/EUR

    1.1612
    -0.0072 (-0.61%)
     
  • GBP/USD

    1.2371
    -0.0068 (-0.55%)
     
  • Bitcoin GBP

    51,909.59
    +708.67 (+1.38%)
     
  • CMC Crypto 200

    1,383.12
    +70.50 (+5.58%)
     
  • S&P 500

    4,960.42
    -50.70 (-1.01%)
     
  • DOW

    37,956.77
    +181.39 (+0.48%)
     
  • CRUDE OIL

    83.31
    +0.58 (+0.70%)
     
  • GOLD FUTURES

    2,406.70
    +8.70 (+0.36%)
     
  • NIKKEI 225

    37,068.35
    -1,011.35 (-2.66%)
     
  • HANG SENG

    16,224.14
    -161.73 (-0.99%)
     
  • DAX

    17,737.36
    -100.04 (-0.56%)
     
  • CAC 40

    8,022.41
    -0.85 (-0.01%)
     

Could This Tiny Biotech Be the David to Mylan's Epipen Goliath?

Could This Tiny Biotech Be the David to Mylan's Epipen Goliath?

Adamis is working on an EpiPen alternative, and the payoff could be huge